Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men

American Journal of Surgical Pathology

Volumn 24, Issue 1, 2000, Pages 74-80

  Kanhai, Robert C J ^a   Hage, J Joris ^a   Van Diest, Paul J ^a   Bloemena, Elisabeth ^a   Mulder, J Wiebe ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Breast; Castration; Estrogens; Histology; Transsexualism

Indexed keywords

ANDROGEN; ANTIANDROGEN; CYPROTERONE ACETATE; ESTROGEN; ETHINYLESTRADIOL;

ACINAR CELL; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BREAST; BREAST CANCER; CASE REPORT; CASTRATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; GYNECOMASTIA; HUMAN; MALE BREAST; METAPLASIA; PROSTATE CANCER;

ADULT; AGED; ANDROGEN ANTAGONISTS; ANILIDES; BREAST; CASTRATION; CYPROTERONE ACETATE; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; FLUTAMIDE; FOLLOW-UP STUDIES; GYNECOMASTIA; HUMANS; MALE; MASTECTOMY, SUBCUTANEOUS; METAPLASIA; ORCHIECTOMY; TIME FACTORS; TRANSSEXUALISM;

EID: 0033958361     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200001000-00009     Document Type: Article

References (16)

1. Asscheman H, Gooren LJG. Hormone treatment in transsexuals. J Psychol Hum Sexual 1992;5:39-54.
2. Bartoli C, Zurrida SM, Clemente C. Phyllodes tumor in a male patient with bilateral gynaecomastia induced by oestrogen therapy for prostatic carcinoma. Eur J Surg Oncol 1991;17:215-7.
3. Burgess HE, Shousha S. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J Pathology 1993;170:37-43.
4. Ganly I, Taylor EW. Breast cancer in a trans-sexual man receiving hormone replacement therapy. Br J Surg 1995;82:341.
5. Hage JJ. Medical requirements and consequences of sex reassignment surgery. Med Sci Law 1995;35:17-24.
6. Holleb AI, Freeman HP, Farrow HJ. Cancer of male breast, part II. N Y State J Medicine 1968;68:656-63.
7. McCarty KS Jr, Tucker JA. Breast. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press, 1992;893-902.
8. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979;48:338-40.
9. Orentreich N, Durr NP. Mammogenesis in transsexuals. J Invest Dennatol 1974;63:142-6.
10. Pritchard TJ, Pankowsky DA, Crowe JP, Abdul-Karim FW. Breast cancer in a male-to-female transsexual - a case report. JAMA 1988;259:2278-80.
11. Ribeiro GG, Phillips HV, Skinner LG. Serum oestradiol-17b, testosterone, luteinizing hormone, and follicle-stimulating hormone in males with breast cancer. Br J Cancer 1980;41:474-7.
12. Rosen PP. Benign proliferative lesions of the male breast. In: Rosen PP, ed. Rosen 's breast pathology. Philadelphia: Lippincott-Raven, 1997:609-17.
13. Schwartz IS, Wilens SL. The formation of acinar tissue in gynecomastia. Am J Pathol 1963;43:797-803.
14. Symmers WC. Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. BMJ 1968;2:83-5.
15. van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 1997;47:337-42.
16. Wollman L. Office management of the postoperative male transsexual. In: Green R, Money J, eds. Transsexualism and sex reassignment. Baltimore: Johns Hopkins Press, 1969:331-3.